Revised. Amendments from Version 1
==================================

The manuscript has been amended, revised in accordance to the constructive comments of the referees the main changes are: - the numbers analysed has been clarified - the focus of the questionnaire has been clarified - the strength and limitations section has been extended

Introduction
============

Intrathecal and epidural morphine improve postoperative analgesia after caesarean section (CS) and hysterectomy and during intrathecal labour analgesia ^[@ref-1]--\ [@ref-3]^. In 1981, the Swedish Society of Anaesthetists conducted a nationwide survey of experience with intrathecal and extradural opiates ^[@ref-4]^. They found intrathecal morphine was administered in total to only 90--150 patients in 10 of 93 responding units, and ventilatory depression requiring treatment with naloxone was needed in six of these patients. Since then, the use of intrathecal and epidural morphine has expanded, with a decrease in the doses used ^[@ref-5]^. Still, the use of intrathecal and epidural morphine in these patient categories vary and the general use in Sweden at present is unknown. Spinal morphine may have undesirable side effects, such as nausea and vomiting, with the most feared side effect being respiratory depression, which is why extended postoperative monitoring is required ^[@ref-6]^. Extended postoperative monitoring demands personal resources and is sometimes difficult to arrange, which may influence the use of spinal morphine.

The primary aim of the present questionnaire survey was to assess the use of intrathecal and epidural morphine in obstetric and gynaecological patients, factors that limit/holdback its use and monitoring routines implemented. Additional aim was to assess the use of other opioids with more rapid onset and shorter duration for these patients.

Methods
=======

This study was conducted in accordance with the principles outlined in the Declaration of Helsinki. Ethical committee approval was not applied for the present study, since the survey concerns only clinical practice and routines and not patient data in accordance to Swedish ethical board guidelines. The permission to carry out the research was obtained from the head of department of each hospital.

Survey participants
-------------------

A questionnaire survey was sent to anaesthesiologists in charge of obstetric anaesthesia units in hospitals in Sweden. In all, 47 obstetric units were identified by the Swedish Medical Birth Register from National Board of Health and Welfare (Sweden).

We identified the anaesthesiologist in charge of the obstetric and gynaecological anaesthesia for each unit by address lists used by Swedish Society of Obstetric Anaesthesia and Intensive Care ( [SFOAI](https://sfai.se/delforeningar/sfoai/om-sfoai/)), and if these were not present the hospital was phoned to get hold of the anaesthesiologist in charge.

Survey questionnaire
--------------------

The survey consisted of 26 questions sent by email to the anaesthesiologists identified in December 2014, and this was repeated in April 2015 to those clinics that had not answered the first questionnaire. The second time the same questionnaire was sent by email and by postal mail, including a return envelope. The email included a letter to the anaesthesiologist and the survey in two versions. The first version was a Word document, possible to fill in by the computer, save and return by email to a special email address for the study purpose only. The second version was a PDF-file that could be printed and filled in by hand and send by post to our hospital address.

The questionnaire ( [Supplementary File 1](#SF1){ref-type="other"} and [Supplementary File 2](#SF2){ref-type="other"}) was designed to reflect how common the use of intrathecal and epidural morphine, fentanyl and sufentanil as adjunct to local anaesthetics for perioperative care of CS and hysterectomy is, and included questions about the routine use of intrathecal morphine for labour analgesia. The anaesthesiologists were asked to approximate the numbers of CS and hysterectomies performed in spinal and epidural anaesthesia, respectively, and specify the numbers of patients administered with opioids, including neuraxial morphine, for the operations performed. We also asked for doses when spinal/epidural opioids are used. When spinal/epidural morphine is marked "not used" we asked for the reasons behind withholding it. Both multiple choice and written answers were collected. Questions about the organisation of monitoring after neuraxial morphine administration, and known serious adverse events that had occurred in their units were also included.

We calculated the size of the different units by using annual total number of performed CS in the units, in order to put our findings, with regards to the routine use of opioids, into perspective. The annual numbers are collected from The Swedish Medical Birth Register from National Board of Health and Welfare (Sweden).

Statistical analysis
--------------------

Data is presented as number and percentage, and range as applicable. No formal statistical tests were used.

Results
=======

Responding clinics
------------------

In total, 32 units of 47 responded to the questionnaires (68%) representing 83% of annual CS in Sweden. Units with a large number of births and CS were more willing to respond. Among the 21 units with more than 2000 births/year 19 units responded (90%) versus 12/25 (48%) units with less than 2000 births/year. In units performing more CS than 300/year 23/28 units responded (82%) versus 9/19 (47%) units with less than 300/year. In the 15 units performing more than 400 CS/year we got 100% response.

Caesarean sections (CS)
-----------------------

The routine use of intrathecal opioids in CS is shown in [Table 1](#T1){ref-type="table"}. All responding units use at least one opioid as adjunct to local anaesthesia in CS.

###### Neuroaxial opioids in Ceasarean section.

IT = intrathecal, EDA = epidural, M= morphine; F= fentanyl; S= sufentanil.

  -------------------------------------------------------------------------------------------------
  Neuroaxial opioids in Ceasarean section     Units N                                         
  ------------------------------------------- -------------------------- -------------------- -----
  Responding rate                             32/47                                           

  Intrathecal                                 Morphine                   IT morphine          20

  IT morphine dose\                           \                                               
  100 µg\                                     17\                                             
  125 µg                                      3                                               

  IT morphine but no IT fentanyl/sufentanil   2                                               

  M+F                                         IT morphine + fentanyl     16                   

  M+S                                         IT morphine + sufentanil   2                    

  Fentanyl                                    IT fentanyl                21                   

  IT fentanyl dose\                           \                                               
  10--14 µg\                                  18\                                             
  15--20 µg                                   3                                               

  IT fentanyl but no IT morphine              5                                               

  Sufentanil                                  IT sufentanil              9                    

  IT sufentanil dose\                         \                                               
  2.5 µg\                                     4\                                              
  5 µg\                                       4\                                              
  5--10 µg                                    1                                               

  IT sufentanil but no IT morphine            7                                               

  Epidural                                    M                          EDA morphine dose\   \
                                                                         1 mg\                1\
                                                                         2 mg\                10\
                                                                         4 mg                 1

  F                                           EDA fentanyl 50--100 µg    10                   

  S                                           EDA sufentanil dose\       \                    
                                              5--10 µg\                  11\                  
                                              15--25 µg\                 3\                   
                                              25--50 µg                  1                    
  -------------------------------------------------------------------------------------------------

***Intrathecal morphine.*** A total of 20 out of 32 units reported the use of intrathecal morphine as routine in CS spinal analgesia. Three units that did not use intrathecal morphine for CS patients commented that they intended to start using intrathecal morphine within the next year.

For CS the most common intrathecal morphine dose was 100 μg, which was used in 17/20 units and three units used 125 μg. All, except for two units, used morphine in combination with either fentanyl or sufentanil. One of these units reported that they plan to start the addition of fentanyl.

***Intrathecal fentanyl.*** Addition of fentanyl in intrathecal CS anaesthesia was used in 21/32 units; 5 units used fentanyl, but no morphine. In total, 18 units used 10--12.5 microgram dose and 3 units used a 15--20 µg dose.

***Intrathecal sufentanil.*** The addition of sufentanil in intrathecal CS anaesthesia was less commonly used; 9/32 units, where seven units use sufentanil as the sole opioid added. Four units used a 2.5 µg dose, 4 units used a 5 µg dose and one unit used a 5--10 µg dose of sufentanil.

Thus, 16 units used the combination morphine/fentanyl, 2 units used the combination morphine/sufentanil and 2 solely used morphine, 5 solely used fentanyl and 7 solely used sufentanil.

***Epidural morphine.*** Addition of epidural morphine to CS performed in epidural anaesthesia was less common than intrathecal morphine in spinal anaesthesia: 12/32 units added morphine to the epidural local anaesthesia. The majority, 10 units, administered 2 mg dose of morphine, one unit used 1 mg and one unit used a 4 mg dose of morphine.

***Epidural fentanyl.*** Ten units added fentanyl (50--100 µg) in the epidural for CS anaesthesia.

***Epidural sufentanil.*** In total, 15 units used sufentanil as the opioid with rapid onset of action in the epidural anaesthesia for CS anaesthesia, where 11 used doses up to 10 µg, 3 units administered doses up to 25 µg, and one unit used a 25--50 µg dose as the sole opioid added.

***Labour analgesia.*** None of the units used morphine in spinal labour analgesia.

Hysterectomy
------------

***Intrathecal morphine.*** Spinal anaesthesia with morphine added is used in 20 of the 32 answering units in hysterectomy. The most common dose was 200 µg administered by 9 clinics, 5 clinics used 120--140 µg, 5 used 100 µg and one unit administered 80 µg.

In other types of gynaecological operations, like perineoraphies, malign robot surgery, all gynaecological abdominal surgery 7/32 clinics used intrathecal morphine. One of 32 clinics used epidural morphine, for malign gynaecological surgery.

***Postoperative monitoring.*** Postoperative monitoring was generally organised within the initial 2--6 hours in the postoperative ward and the following hours, up to 12 hours, in the regular surgical ward, according to the guidelines of -- Swedish Society of Anaesthesia and Intensive Care ( [SFAI](https://sfai.se/wp-content/uploads/files/21-9RiktlinjerförpostoperativsmärtbehandlingB.pdf)). In case of CS the initial 2--6 hours of postoperative monitoring were located to either the obstetrical ward (as it was in eight hospitals as routine and in some hospitals occasionally) or the postoperative ward and the following hours, up to 12 hours, in the regular ward.

Seven of the 12 units that did not use spinal/epidural morphine describe risk of respiratory depression and difficulties to monitor as the main reasons for withholding its use. One unit answered they routinely used intrathecal morphine for CS but did not present any dose of intrathecal morphine, only sufentanil and is consequently not included in [Table 1](#T1){ref-type="table"} among morphine use and we considered the unit as none user of morphine.

###### 

Click here for additional data file.
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Discussion
==========

We found that all responding units used opioid supplementation and two thirds of responding units obstetric anaesthesia units in Sweden used spinal/epidural morphine as adjunct to local anaesthesia for perioperative care of CS and hysterectomies. Spinal use was rather uniform with 100 µg for CS and up to 200 µg for hysterectomies of intrathecal morphine combined with a low dose of fentanyl or sufentanil. Epidural morphine was used to a lesser extent. Opioids, such as sufentanil were also commonly added to labour analgesia, but no unit used morphine as an adjunct in labour analgesia. The common reason for withholding spinal/epidural opioid was the risk for respiratory depression, and thus the demands for post procedural monitoring.

There were some obvious differences in practice in the different units. Winther *et al.* found likewise inconsistencies in clinical guidelines for obstetric anaesthesia for CS ^[@ref-7]^. The most effective method for providing pain relief during labour is epidural analgesia ^[@ref-8]^. There are good opportunities to get a labour epidural in Sweden for every woman who wish for one since it was legislated 1971. In countries with limited resources, a single shot spinal anaesthesia may be a feasible option. Combination of low dose morphine, fentanyl and bupivacaine or morphine, sufentanil and bupivacaine are suggested to achieve effective analgesia with a prolonged effect ^[@ref-9]^. However, we were previously unable to find a major advantage of the addition of morphine, when comparing 0, 50 or 100 μg morphine added to 1.25 mg bupivacaine and 5 μg sufentanil during established labour, as this did not show a significant increased duration of analgesia ^[@ref-10]^. Morphine is not a preferred drug for labour epidural analgesia and questions about the addition of opioids other than morphine to labour epidurals were not included in this survey. Adding sufentanil or fentanyl is common practice, and may be seen more or less as the gold standard ^[@ref-11],\ [@ref-12]^. Sufentanil is the most common opioid added in labour anaesthesia in Sweden, which was reported in a national obstetric anaesthesia meeting from a survey in 2009 (Data on file).

Spinal anaesthesia is the preferred analgesia in CS when a labour epidural is not in place to top-up for perioperative use. Long acting spinal opioids as a component of the CS spinal anaesthesia has been proven superior as the post-caesarean analgesia over systemic counterparts, and made them a commonly used part of multimodal analgesic regimes ^[@ref-13]^. In Sweden, the long acting opioid most commonly used in CS is morphine, and we found that 63% of units used intrathecal morphine as routine in CS spinal analgesia. Since larger units with higher numbers of CS more commonly used intrathecal morphine, the impact of the routine was even more pronounced. The units that used intrathecal morphine as routine adjunct to local anaesthesia in CS, covered an estimated 73% of all CS annually performed in responding units. All responding units used intrathecal morphine doses of 100--125 µg. Palmer *et al.* found in a dose response study that morphine at 100 µg added to hyperbaric bupivacaine (12.75 mg) provided analgesia comparable to that provided by doses as high as 500 µg ^[@ref-1]^. The optimal effective dose for CS is not well defined. The balance between analgesia and side effects must be taken into account. The occurrence of pruritus, has been found to be dose related ^[@ref-1],\ [@ref-6],\ [@ref-14]^. For nausea and vomiting the relationship is not that clear but nausea and vomiting is seen in a higher frequency in higher doses than in lower dose groups ^[@ref-14]^.

Intrathecal morphine is suggested to provide better pain control after CS than opioid-free epidural analgesia ^[@ref-15]^. Intrathecal morphine has also been shown superior regarding postoperative pain relief, as compared to abdominal wall block (TAP) ^[@ref-13]^. The more lipophilic diamorphine was the most commonly used opioid in a survey conducted in the UK in 2008 ^[@ref-5]^. Diamorphine has a more rapid onset of action than morphine because of a high lipophilicity (octanol-water coefficient =280) ^[@ref-16]^. Diamorphine is metabolised to morphine with long-acting activity; however, diamorphine is not registered/available as pharmaceutical drug in Sweden ^[@ref-16]^. Fentanyl and sufentanil are the available lipid-soluble opioids used, with a quick onset for improved perioperative spinal and epidural analgesia ^[@ref-17]^. A combination of one lipid-soluble opioid and the long-acting water-soluble morphine is added to hyperbaric bupivacaine, which was found to be commonly used in Sweden. It is an attractive combination providing a quick onset with improved perioperative quality and a long- acting postoperative analgesia ^[@ref-16]^. Yet currently, the present study found that twelve units use solely lipophilic opioid adjuncts with rapid onset and shorter duration to local anaesthesia and two of the units add morphine to local anaesthetics with no addition of fentanyl or sufentanil. Intrathecal.lipophilic opioids in CS are not as effective as intrathecal morphine, they still proved to be beneficial during the period of highest analgesic demand after CS ^[@ref-18]^.

When a functional labour epidural is in place, it's recommended to convert this to a full epidural anaesthesia if an emergency CS becomes necessary ^[@ref-19]^. Twelve of the 32 units added morphine to the epidural local anaesthesia, the most common dose was 2 mg. Singh *et al.* found epidural morphine at 1.5 mg provided none-inferior post caesarean analgesia and caused fewer adverse effects compared with 3 mg epidural morphine ^[@ref-20]^. Still the majority of responding units decided not to add morphine in epidural analgesia for CS postoperative analgesia. The addition of sufentanil (15 units) or fentanyl (9 units) was more common, together covering 74% of CS performed annually in responding clinics. Malhotra *et al.* found no support for adding 75 µg fentanyl in top-up epidural for CS regarding time to onset nor quality of analgesia in women already receiving epidural fentanyl during labour ^[@ref-21]^. Others argue the addition of epidural opioids fastens onset and enhance postoperative analgesia after CS ^[@ref-22],\ [@ref-23]^.

The addition of morphine intrathecal or epidural as adjunct for intra as well as postoperative pain relief is also regarded by many as the 'gold-standard', due to its positive analgesic interaction with local anaesthetics and prolonged duration of action ^[@ref-6]^. Spinal anaesthesia with added morphine was used in 63% of responding units for hysterectomy perioperative analgesia. The use of intrathecal morphine analgesia, sometimes as complement to general anaesthesia, has gained popularity in Sweden due to its simplicity to administer with no need for epidural or patient control analgesia infusions, and good results regarding postoperative pain ^[@ref-2]^. The most common dose used was 200 µg, which is the well in line with the optimal dose found in a study of the three doses (100 µg, 200 µg and 300 µg) versus placebo in abdominal hysterectomy ^[@ref-2]^. Intrathecal morphine use in hysterectomy varied regarding type of surgical technique: 5 units used intrathecal morphine in abdominal, vaginal and laparoscopic hysterectomies, while 7 units used intrathecal morphine in abdominal and vaginal, but not in laparoscopic, hysterectomy.

All responding units had guidelines regarding postoperative monitoring after neuraxial opioids. The routine of dividing the postoperative monitoring between a more monitoring intensive postoperative ward for the first 2--6 hours and a regular surgical ward for the following hours, up to 12 hours, according to the guidelines of SFAI, was common, and was found to be already routine in a European survey in 1996 by Rawal *et al* ^[@ref-24]^. In 8 units, CS were initially monitored for 2--6 hours in the obstetrical ward. Two units using intrathecal morphine for CS monitored postoperatively only in a regular maternity ward for the whole period. Seven of the 12 units that did not to use spinal/epidural morphine described a risk of respiratory depression and difficulties to monitor postoperatively as the main reason for withholding its use. In these units, which did not use morphine because of risk for respiratory depression and difficulties in postoperative monitoring, approximately 15% of CS reported were performed.

Respiratory depression is the most serious side effect associated with neuroaxial morphine; however, its occurrence is rare ^[@ref-6]^. In 2010, the subject " *All patients receiving neuraxial morphine should be monitored with continuous pulse oximetry*" was debated during Controversies in Obstetric Anesthesia ^[@ref-25]^. It was commented that a requirement for pulse oximetry might decrease the use of neuraxial morphine as post caesarean analgesia and risk more pain in patients with more parenteral morphine consumed with the risk of increased risk of respiratory depression ^[@ref-6]^. We have in our institution some 15 years' experience of approximately 2000 annual CS performed, the majority in spinal anaesthesia using a combination of fentanyl (10 µg), morphine (100 µg) and hyperbaric bupivacaine (10--12 mg). Our routine is an initial 2--3 postoperative hours monitoring in a postoperative ward, and the following hours up to 12 hours in the maternity regular ward with midwife hourly supervision of level of consciousness and in case of sedated (sleeping) patient monitoring of respiratory rate, according to the guidelines of SFAI. In the case of an unstable patient, morbid obesity or known sleep apnoea, the patient stays in the postoperative department for a longer time, determined on an individual basis. In line with responding units in this survey, we have no known experience from severe respiratory depression.

The return rate of the questionnaire was 32/47 units (68%), a figure in line with previous questionnaire survey around anaesthesia practice in conjunction to obstetrics ^[@ref-26],\ [@ref-27]^. Considering the size of the different units, the response routines cover approximately 82% out of 111,364 annual deliveries, as seen in The Swedish Medical Birth Register (2013), and 83% of CS are performed in responding units.

Limitations
===========

Our main interest was to find the routine use of morphine in CS, since we learned from anaesthesia meetings with colleges that this routine, regarded as "gold standard" was not in use in several units, due to fear of respiratory depression ^[@ref-6]^. The questionnaire was answered by anaesthesiologists in charge of obstetric anaesthesia routines in the departments but the presented routines may not show the whole truth about general choice of treatment since implementation of routines vary. We included questions regarding spinal/epidural addition of fentanyl and sufentanil as well, but did not in detail ask for monitoring after these adjuvants when morphine was not included. We postulated postoperative monitoring was practiced according to the guidelines of SFAI and defined in brackets regarding intrathecal morphine "pain by visual analogue scale, sedation, and in case of sedation respiratory rate monitoring for 12 hours". Our questions about monitoring focused mainly on time and location and we did not ask for more information about how the monitoring was specified and conducted. We asked for numbers of performed CS and hysterectomies, including morphine, for each unit. However, those numbers were not possible to extract from the questionnaire because of few answers. When the majority of anaesthesia units are reporting anaesthesia to the Swedish PeriOperative Register ( [SPOR](http://www.spor.se)), hopefully in the coming years there will be better opportunities to answer questions about common routines and outcomes. We included one question regarding knowledge of serious complications in the unit associated with neuraxial anaesthesia. The quality of the obtained negative answers from this question may be considered low but we were interested in known complications. If serious complications had occurred, it is likely that the anaesthesiologist in charge would know.

Conclusion
==========

The use of neuraxial opioids is widely spread in Sweden; however somewhat varying regimes exists, where some units chose to use only lipophilic opioids with a rapid onset and few use only long-acting water-soluble morphine. However, a majority use a combination together with local anaesthesia. Still in some units the use of morphine is restricted because of the concern for respiratory depression and difficulties in monitoring.

Data availability
=================

The data referenced by this article are under copyright with the following copyright statement: Copyright: © 2017 Hein A et al.

Data associated with the article are available under the terms of the Creative Commons Zero \"No rights reserved\" data waiver (CC0 1.0 Public domain dedication). <http://creativecommons.org/publicdomain/zero/1.0/>

Dataset 1: Raw data for IT and EDA opioid survey. IT, intrathecal; EDA, epidural; MO, morphine. doi, [10.5256/f1000research.10705.d151418](http://dx.doi.org/10.5256/f1000research.10705.d151418) ^[@ref-28]^

Supplementary material
======================

Supplementary File 1: Questionnaire in Swedish.

Click here for additional data file..

Supplementary File 2: Questionnaire in English.

Click here for additional data file..
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Thank you for correcting the manuscript. In my opinion, the manuscript has improved significantly and all comments have been addressed. The aim of the study and the results are presented in a clear manner. Table 1 has improved greatly!
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Version 1

The study of Hein et al. presents results of a nation-wide survey on the use of neuraxial opioids in obstetric and gynecology patients in Sweden. I found especially interesting these parts that were devoted to cesarean section (CS). Multimodal analgesia became a widely used approach to post-CS pain management and the use of intrathecal opioids is one of the important components in this approach. Among intrathecal opioids, low-dose morphine appear to be the most widely recommended ^[@rep-ref-20178-1]^. However, this hydrophilic opioid has a high frequency of adverse effects ^[@rep-ref-20178-2]^ such us nausea and vomiting, pruritus, and potentially serious late respiratory depression ^[@rep-ref-20178-3]^. That's why the question of the current routines related to this topic in Sweden is important in daily life clinical practice.

I think that several things could be corrected to improve quality of the paper.

[General comments:]{.ul}

Authors should choose tense in which they present and discuss findings. Personally, I don't like to present tense because, as stated below it can be sometimes misleading. Anyway, consistency is needed.

English language could also be improved. There are some awkward expressions such as 'fast opioid' which is not really medical term.

[Specific comments:]{.ul}

Title:

The title could be more clear and in better English.

Abstract:

I recommend to maintain consistency regarding the aim of the study, whether it is the use of neuraxial opioids or just morphine.

'the patient [is]{.ul} in postoperative care or an obstetrical ward over 2-6 hours and up-to 12 hours in an ordinary surgical ward.' I would add 'is monitored in ...'

Introduction

'Intrathecal and epidural morphine improve postoperative analgesia after caesarean section (CS) and hysterectomy and [intrathecal labour analgesia']{.ul}. Did the authors mean [during]{.ul} intrathecal labour analgesia? This is at least what Yeh et al. had in mind during their study.

Methods:

'A questionnaire survey was sent to anaesthesiologists in charge of Swedish obstetric anaesthesia' I think it sounds a bit strange. Is it not more simple just to write that the questionnaire was sent to the anaesthesiologists in charge of obstetric anaesthesia units in hospitals in Sweden? Furthermore, information about anesthesiologist is repeated 3 times.

What is 'Swedish Association of Obstetric Anaesthesia and Intensive Care'?

The questionnaire (Supplementary File 1 and Supplementary File 2) was [produced to reflect]{.ul} how common the use of intrathecal and epidural morphine, fentanyl and sufentanil as adjunct to local anaesthetics for perioperative care of CS and hysterectomy is, [and also the routine use of intrathecal morphine for labour analgesia]{.ul}. I think this sentence could be corrected in underlined parts as it sounds awkward.

'specify the numbers of patients administered with opioids, including neuraxial morphine, for the operations performed' it is not clear if the authors were interested in intrathecal morphine alone or in other intrathecal opioids or, what would be even more interesting what was the combinations of used opioids. It is the same issue what with the aim of the study.

Results

'Epidural sufentanil. In total, 15 units use sufentanil as the [fast opioid]{.ul} in the epidural anaesthesia for CS anaesthesia' maybe opioid with rapid onset of action.

50mcg of epidural sufentanil is quite a large dose. I think it should be commented.

It is quite surprising that for hysterectomy and gynecological abdominal surgery opioids are used intrathecally and not with the use of epidural anesthesia. Can the authors comment on that?

'Postoperative monitoring is generally organized within the initial 2--6 hours in the postoperative ward and the following hours, up to 12 hours, in the regular surgical ward, according to the guidelines of SFAI -- Swedish Association of Anaesthesia and Intensive Care.' Did you mean this is general routine in Sweden or this was the result of survey? Using present tense in result section is a bit misleading. Also 'in the regular surgical ward, according to the guidelines of SFAI -- Swedish Association of Anaesthesia and Intensive Care.' I would change into: ... according to the guidelines of Swedish Association of Anaesthesia and Intensive Care (SFAI).

Postoperative monitoring: The authors write about 9 units of 32 in case of CS, what happened to patients in the rest of 20 units where morphine was used?

'Seven of the eleven units that chose not to use spinal/epidural morphine' Or was it 12/32 units which did not use morphine as in table 1.

Discussion

I think authors should avoid expressions such as 'Swedish obstetric anaesthesia' because such thing do not exist. Use instead obstetric anaesthesia units in Sweden.

'Opioids were also commonly added to labour analgesia as sufentanil,' please change for clarity into: 'Opioids such as sufentanil were also commonly added to labour analgesia... '

'there are good opportunities to get a beneficial epidural in Sweden' what did you mean by 'beneficial'? The citation should be placed earlier, as Cochrane's review does not say much how these issues occur in Sweden.

'Sufentanil is the most common opioid added in labour anaesthesia in Sweden, which was reported in a national obstetric anaesthesia meeting from a survey in 2009 (not published).' Oral presentations that were not published should not be mentioned or cited in a good quality paper.

'Spinal anaesthesia is the preferred analgesia in CS when a working epidural is not in place for conversion and top-up.' What do you mean 'conversion'?

'Yet currently, the present study found that twelve units use solely fast opioid adjuncts to local anaesthesia and two of the units add morphine to local anaesthetics with no addition of fentanyl or sufentanil, [but one of the units stated they plan to start adding fentanyl shortly.']{.ul} Last part of the sentence could be omitted; the authors should filter not important information. On the other hand it could be discussed that event though intrathecal lipophilic opioids in CS are not as effective as intrathecal morphine, they still proved to be beneficial during the period of highest analgesic demand after cesarean section ^[@rep-ref-20178-4]^.

'Yet, the addition of epidural opioids has been proven to enhance postoperative analgesia after CS with earlier onset' I don't understand this sentence.

Withdrawing from the use of intrathecal morphine could be discussed in context of other large studies that report usage of intrathecal opioids in obstetrics ^[@rep-ref-20178-5]^ ^-^ ^[@rep-ref-20178-7]^.

Limitation

Usually, at the end of manuscript, authors should state limitations of the study. Some aspects that could be discussed are:

The postoperative monitoring routines are limited to time perspective. There is nothing about what was actually monitored and how often.

Quality of information obtained from the question regarding complications is very low.

I have read this submission. I believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.
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The present study explores the use of opioids in obstetric and gynaecological surgery in Sweden. The authors have done a nice survey among Swedish hospitals covering a majority of the procedures performed. The study is properly designed, the results reported correctly with adequate clinically relevant conclusions. However, some revisions are needed in the manuscript.

**Throughout the manuscript please revise the language according to tenses and report the results in "past time".** Please use a consequent numbering format with numbers and letters.

Consider sending the manuscript for language proof reading to improve the quality.

**Abstract:**

Change "...47 anaesthesiologists at ob. units..." to "... all anaesthetic obstetric unit.."

**Introduction:**

Line 5: 90-150 of how many??

**Methods:**

*"..26 questions sent by mail..."*  Please specify postal mail

*"...questionnaire was produced to reflect...."*  Designed or Formulated might be better than Produced

"...no formal statistical tests [WERE]{.ul} used." Please use past form.

**Results**

Regarding the responding clinics, was it 32 units that responded with postal mail? Or total response rate? Consider deleting the word "mailed".  The results here are not in accordance with the results in the abstract where you state that the units represented 83% of annual CS.

Better formulation may be:  "... 32 of 47 (68%) units responded to the questionnaires representing 83 % of annual CS in Sweden\..."

Please provide proof that larger units were more willing to respond. Significant? 

Please be consequent with the dosing: now both [µg]{.ul} and [microgram]{.ul} are used.

Section epidural morphine:

Table 1: The table is difficult to view in the current layout.

Suggestion

\-\-\-\-\-\--

                        Number of units

**Response rate 32/47**

**Intrathecal morphine  20**

Standard dose 100 µg           17

Standard dose 125 µg            3

Combined with fentanyl        16

Combined with sufentanil       2

**Intrathecal Fentanyl   21**

Standard dose 10-14 µg        18

Etc...

\-\-\-\-\-\-\-\-\-\-\-\--

**Discussion**

Please add "...all [responding]{.ul} units used...." to the first sentence.

"...a survey in 2009 (not published)".  I "Data on file" might be a better formulation than "not published"

"The addition of sufentanil (15 units) or fentanyl (9units...)" Please reformulate so that it is clear that you mean number of OB/Gyn units and not units of the drugs.

Last paragraph of the Discussion: Move the results to the first part of the results section.

Please also include limitations of the study in the discussion. Were there any pit-falls? Can the results be generalised outside Sweden? The standard care for the units are reported, but is there a variability at the units that has to be discussed?

Consider reducing the length of the discussion.
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